A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic.

Source:http://linkedlifedata.com/resource/pubmed/id/1830238

Cancer 1991 Aug 15 68 4 730-2

Download in:

View as

General Info

PMID
1830238